Structural and functional characterization of the product of disease-related factor H gene conversion
about
Structural basis for sialic acid-mediated self-recognition by complement factor HProperdin: a tightly regulated critical inflammatory modulatorRenal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.Liver transplantation for aHUS: still needed in the eculizumab era?Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.Factor H C-Terminal Domains Are Critical for Regulation of Platelet/Granulocyte Aggregate Formation.FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.Atypical hemolytic uremic syndrome
P2860
Q27696183-BF81575A-4766-43B2-A0F5-47FDE6E4765CQ28069187-29B23827-80C2-4DA3-94C2-B5194B613437Q33400705-B1CF2A72-7858-4FEE-8F61-8B8D46D2CABBQ33405609-CF17A949-8DAC-4F61-B1B8-90A4B1052A06Q33420213-1B94F121-EE44-4EE3-920F-BBB6CED9B486Q33427846-AC75CF0A-1875-4DCF-8378-9C00B45563FCQ34427591-9BEEAE87-B9B0-4E48-B455-76D53C8400F0Q34489424-99DE872E-7CA4-4F8C-A028-EDE0D8118150Q36913660-72A202C8-9EB8-4B43-9762-71310567E996Q41377869-E1E3CB0F-C650-4C2F-8839-157A35BBD704Q47100595-20B2CCF6-98E7-464E-9DFD-2623DC7DB818Q48113964-0935A11C-68ED-49DA-A44A-AC98741A1775Q51730313-6C9A4243-B35A-48E3-A7F2-0EE6A827E692Q56591965-8A3666C0-6B99-4133-BD20-0711289BE4AE
P2860
Structural and functional characterization of the product of disease-related factor H gene conversion
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Structural and functional char ...... lated factor H gene conversion
@ast
Structural and functional char ...... lated factor H gene conversion
@en
Structural and functional char ...... lated factor H gene conversion
@nl
type
label
Structural and functional char ...... lated factor H gene conversion
@ast
Structural and functional char ...... lated factor H gene conversion
@en
Structural and functional char ...... lated factor H gene conversion
@nl
prefLabel
Structural and functional char ...... lated factor H gene conversion
@ast
Structural and functional char ...... lated factor H gene conversion
@en
Structural and functional char ...... lated factor H gene conversion
@nl
P2093
P50
P3181
P356
P1433
P1476
Structural and functional char ...... lated factor H gene conversion
@en
P2093
Bärbel S Blaum
Conny Johansson
Dušan Uhrín
Hugh P Morgan
Paul N Barlow
P304
P3181
P356
10.1021/BI201689J
P407
P577
2012-03-06T00:00:00Z